Literature DB >> 26932584

Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban.

Maja Hellfritzsch1, Per Damkier1,2, Anton Pottegård1, Thor Grønlykke3, Erik L Grove4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26932584     DOI： 10.1002/pds.3916

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  3 in total

1.  Pharmacokinetics of apixaban.

Authors:  Penny Beirne
Journal:  Aust Prescr       Date:  2017-06-01

2.  Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy.

Authors:  Sergey V Brodsky; Nilesh S Mhaskar; Sampath Thiruveedi; Rajnish Dhingra; Sharon C Reuben; Edward Calomeni; Iouri Ivanov; Anjali Satoskar; Jessica Hemminger; Gyongyi Nadasdy; Lee Hebert; Brad Rovin; Tibor Nadasdy
Journal:  Kidney Res Clin Pract       Date:  2017-12-31

Review 3.  Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance.

Authors:  Riccardo Vio; Riccardo Proietti; Matteo Rigato; Lorenzo Arcangelo Calò
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.